Outcomes With 5-Fluorouracil, Doxorubicin, and Streptozocin (FAS) and Subsequent Therapies in Patients With Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs)

被引：0
|
作者：
Lam, Michael [1 ]
Rogers, Jane [1 ]
Halperin, Daniel [1 ]
Dagohoy, Cecile [1 ]
Yao, James [1 ]
Dasari, Arvind [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
PANCREAS | 2019年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [1] Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors
    Rogers, Jane E.
    Lam, Michael
    Halperin, Daniel M.
    Dagohoy, Cecile G.
    Yao, James C.
    Dasari, Arvind
    NEUROENDOCRINOLOGY, 2022, 112 (01) : 34 - 42
  • [2] Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
    Antonodimitrakis, Pantelis Clewemar
    Sundin, Anders
    Wassberg, Cecilia
    Granberg, Dan
    Skogseid, Britt
    Eriksson, Barbro
    NEUROENDOCRINOLOGY, 2016, 103 (3-4) : 345 - 353
  • [3] Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors
    Eriksson, B.
    Sundin, A.
    Wassberg, C.
    Skogseid, B.
    Antonodimitrakis, P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S145 - S145
  • [4] Evaluation of the Combination 5-Fluorouracil, Dacarbazine, and Epirubicin in Patients With Advanced Well-Differentiated Neuroendocrine Tumors
    Walter, Thomas
    Bruneton, Domitille
    Cassier, Philippe A.
    Hervieu, Valerie
    Pilleu, Frank
    Scoazec, Jean Yves
    Chayvialle, Jean Alain
    Lombard-Bohas, Catherine
    CLINICAL COLORECTAL CANCER, 2010, 9 (04) : 248 - 254
  • [5] Evaluation of the Combination 5-Fluorouracil, Dacarbazine and Epirubicin in Patients with Advanced Well-Differentiated Neuroendocrine Tumors
    Bruneton, D.
    Walter, T.
    Cassier, P.
    Hervieu, V
    Pilleul, F.
    Scoazec, J. Y.
    Chayvialle, J. A.
    Lombard-Bohas, C.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 101 - 101
  • [6] Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors Case series
    Mueller, Christian
    Kreissl, Michael C.
    Klose, Silke
    Krause, Andreas
    Keitel, Verena
    Venerito, Marino
    MEDICINE, 2022, 101 (04) : E28610
  • [7] Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors
    Prakash, Laura
    Bhosale, Priya
    Cloyd, Jordan
    Kim, Michael
    Parker, Nathan
    Yao, James
    Dasari, Arvind
    Halperin, Daniel
    Aloia, Thomas
    Lee, Jeffrey E.
    Vauthey, Jean Nicolas
    Fleming, Jason B.
    Katz, Matthew H. G.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (01) : 155 - 163
  • [8] Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors
    Laura Prakash
    Priya Bhosale
    Jordan Cloyd
    Michael Kim
    Nathan Parker
    James Yao
    Arvind Dasari
    Daniel Halperin
    Thomas Aloia
    Jeffrey E. Lee
    Jean Nicolas Vauthey
    Jason B. Fleming
    Matthew H. G. Katz
    Journal of Gastrointestinal Surgery, 2017, 21 : 155 - 163
  • [9] Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
    Dilz, Lisa-Marie
    Denecke, Timm
    Steffen, Ingo G.
    Prasad, Vikas
    von Weikersthal, Ludwig Fischer
    Pape, Ulrich-Frank
    Wiedenmann, Bertram
    Pavel, Marianne
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1253 - 1262
  • [10] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Harald Lahner
    Annie Mathew
    Anna Lisa Klocker
    Nicole Unger
    Jens Theysohn
    Jan Rekowski
    Karl-Heinz Jöckel
    Sarah Theurer
    Kurt Werner Schmid
    Ken Herrmann
    Dagmar Führer
    Endocrine, 2022, 75 : 293 - 302
12345